drugset / Trial / NCT02001285

Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Double-lumen Endobronchial Intubation

NCT02001285

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is the comparison of the effect-site concentration of remifentanil for blunting hemodynamic responses to ordinary tracheal and double-lumen endobronchial intubation during propofol-remifentanil total intravenous anesthesia.

Timeline

Start
2013-10
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 3.5 ng/ml

Indications

No indication recorded.